1 (833) 242-CURE (2873) info@specicare.com
Abbott Just Bet $21 Billion on Advanced Cancer Testing – Why It’s a Good Bet

Abbott Just Bet $21 Billion on Advanced Cancer Testing – Why It’s a Good Bet

The $21 Billion Wake-Up Call Advanced Cancer Testing Is Eating Standard Cancer Care When a global medtech giant like Abbott spends about $21 billion to acquire a cancer-testing company, it’s not just a business headline—it’s a message about where cancer care is really...